tiprankstipranks
West Pharmaceutical price target lowered to $315 from $350 at KeyBanc
The Fly

West Pharmaceutical price target lowered to $315 from $350 at KeyBanc

KeyBanc analyst Paul Knight lowered the firm’s price target on West Pharmaceutical to $315 from $350 and keeps an Overweight rating on the shares. Knight sees multiple indicators providing high visibility for the firm’s FY23 quarters and FY25 annual estimates, the analyst tells investors in a research note.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on WST:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles